Dyne Therapeutics

Dyne Therapeutics

Focused on delivering functional improvement for people living with genetically driven neuromuscular diseases

Location
Roles tracked
0
In pipeline
0
Tracking since

At a glance

You're tracking 0 roles at Dyne Therapeutics. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
320 people
Headquarters
Waltham, Massachusetts
Founded
2018
Type
Public Company
Total funding
$2.3B

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more https://www.dyne-tx.com/. To view our community guidelines, click here: https://bit.ly/3BYPnpK

Health Care Biotechnology Medical Pharmaceutical Therapeutics

Open roles at Dyne Therapeutics